Gattermann N - Search Results

1

The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification.

Nachtkamp K, Strupp C, Vukelja M, Kasprzak A, Haase D, Ganster C, Hildebrandt B, Betz B, Giagounidis A, Aul C, Blum S, Hofmann WK, Pfeilstöcker M, Valent P, Lübbert M, Seidl M, Rudelius M, Stauder R, Krieger O, Götze KS, Bobak J, Kündgen A, Schulz F, Dietrich S, Kobbe G, Gattermann N, Germing U. Nachtkamp K, et al. Among authors: gattermann n. Leukemia. 2024 Feb;38(2):442-445. doi: 10.1038/s41375-024-02157-2. Epub 2024 Jan 23. Leukemia. 2024. PMID: 38263435 Free PMC article. No abstract available.

2

Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf score.

Aul C, Gattermann N, Germing U, Runde V, Heyll A, Schneider W. Aul C, et al. Among authors: gattermann n. Leukemia. 1994 Nov;8(11):1906-13. Leukemia. 1994. PMID: 7967735

3

Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients.

Germing U, Gattermann N, Strupp C, Aivado M, Aul C. Germing U, et al. Among authors: gattermann n. Leuk Res. 2000 Dec;24(12):983-92. doi: 10.1016/s0145-2126(00)00088-6. Leuk Res. 2000. PMID: 11077111

4

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).

Germing U, Hildebrandt B, Pfeilstöcker M, Nösslinger T, Valent P, Fonatsch C, Lübbert M, Haase D, Steidl C, Krieger O, Stauder R, Giagounidis AA, Strupp C, Kündgen A, Mueller T, Haas R, Gattermann N, Aul C. Germing U, et al. Among authors: gattermann n. Leukemia. 2005 Dec;19(12):2223-31. doi: 10.1038/sj.leu.2403963. Leukemia. 2005. PMID: 16193087

5

The role of low-dose chemotherapy in myelodysplastic syndromes.

Aul C, Gattermann N. Aul C, et al. Among authors: gattermann n. Leuk Res. 1992;16(3):207-15. doi: 10.1016/0145-2126(92)90058-f. Leuk Res. 1992. PMID: 1560670 Review.

6

Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.

Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W. Aul C, et al. Among authors: gattermann n. Leukemia. 1992 Jan;6(1):52-9. Leukemia. 1992. PMID: 1736014

7

Epidemiological and etiological aspects of myelodysplastic syndromes.

Aul C, Gattermann N, Schneider W. Aul C, et al. Among authors: gattermann n. Leuk Lymphoma. 1995 Jan;16(3-4):247-62. doi: 10.3109/10428199509049764. Leuk Lymphoma. 1995. PMID: 7719233 Review.

8

Is acquired idiopathic sideroblastic anemia (AISA) a disorder of mitochondrial DNA?

Gattermann N, Aul C, Schneider W. Gattermann N, et al. Leukemia. 1993 Dec;7(12):2069-76. Leukemia. 1993. PMID: 8255108 Review. No abstract available.

9

Fatal hyperleukocytic syndrome in a patient with chronic myelomonocytic leukemia.

Aul C, Gattermann N, Germing U, Südhoff T, Hollmig KA, Heyll A. Aul C, et al. Among authors: gattermann n. Leuk Res. 1997 Mar;21(3):249-53. doi: 10.1016/s0145-2126(96)00117-8. Leuk Res. 1997. PMID: 9111170

10

Increasing incidence of myelodysplastic syndromes: real or fictitious?

Aul C, Germing U, Gattermann N, Minning H. Aul C, et al. Among authors: gattermann n. Leuk Res. 1998 Jan;22(1):93-100. doi: 10.1016/s0145-2126(97)00089-1. Leuk Res. 1998. PMID: 9585086

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters